formestane has been researched along with dehydroepiandrosterone in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (41.67) | 18.7374 |
1990's | 3 (25.00) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 1 (8.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gynther, J; Honkakoski, P; Jyrkkärinne, J; Mäkinen, J; Poso, A; Savolainen, H | 1 |
Bellavance, E; Luu-The, V; Poirier, D | 1 |
Deckers, GH; Geelen, JA; Kloosterboer, HJ; Loozen, HJ; Tax, LJ; van der Wardt, JT | 1 |
Brodie, AM; Coombes, RC; Dowsett, M; Gazet, JC; Goss, PE; Hutchison, G; Powles, TJ | 1 |
Albrecht, ED; Anderson, LD; Pepe, GJ; Wunsch, DM | 1 |
Abul-Hajj, YJ | 1 |
Choi, L; Haning, RV; Kiggens, AJ; Kuzma, DL; Summerville, JW | 2 |
Gaillard, JL; Moslemi, S; Silberzahn, P | 1 |
Bruder, JM; Oettel, M; Sobek, L | 1 |
Klinga, K; Mayer, D; Morfin, R; Schmitt, M; Schnarr, B | 1 |
Csákvári, E; Gyenes, A; Hoyk, Z; Kóti, J; Paragi, G; Párducz, A; Pfoh, R; Rühl, S; Szájli, A; Wölfling, J | 1 |
12 other study(ies) available for formestane and dehydroepiandrosterone
Article | Year |
---|---|
Molecular determinants of steroid inhibition for the mouse constitutive androstane receptor.
Topics: Animals; Cell Line; Constitutive Androstane Receptor; Histone Acetyltransferases; Humans; Mice; Models, Molecular; Mutation; Nuclear Proteins; Nuclear Receptor Co-Repressor 1; Nuclear Receptor Coactivator 1; Protein Structure, Secondary; Quantitative Structure-Activity Relationship; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Repressor Proteins; Steroids; Transcription Factors; Two-Hybrid System Techniques; Yeasts | 2003 |
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity | 2009 |
Selection of 19-(ethyldithio)-androst-4-ene-3,17-dione (ORG 30958): a potent aromatase inhibitor in vivo.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dogs; Estradiol; Estrus; Female; Gonadotropins, Equine; Humans; In Vitro Techniques; Male; Ovariectomy; Ovary; Ovulation; Rats; Rats, Inbred Strains; Testosterone | 1991 |
Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.
Topics: Adult; Aged; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Dehydroepiandrosterone; Drug Evaluation; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Sex Hormone-Binding Globulin | 1986 |
Regulation of progesterone formation by human placental cells in culture.
Topics: Androstenedione; Cells, Cultured; Dehydroepiandrosterone; Dihydrotestosterone; DNA; Estradiol; Estrogen Antagonists; Ethamoxytriphetol; Female; Humans; Placenta; Pregnancy; Progesterone; Time Factors | 1986 |
Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
Topics: Aminoglutethimide; Androgens; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Cyanoketone; Dehydroepiandrosterone; Estrogens; Female; Humans; Kinetics; Oxidoreductases; Receptors, Estrogen | 1982 |
Effects of dibutyryl cAMP, LHRH, and aromatase inhibitor on simultaneous outputs of prostaglandin F2 alpha, and 13,14-dihydro-15-keto-prostaglandin F2 alpha by term placental explants.
Topics: Androstenedione; Aromatase Inhibitors; Bucladesine; Chorionic Gonadotropin; Culture Techniques; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dinoprost; Female; Gonadotropin-Releasing Hormone; Humans; Kinetics; Lipoproteins, LDL; Placenta; Pregnancy; Prostaglandins F | 1982 |
Effects of dibutyryl adenosine 3',5'-monophosphate, luteinizing hormone-releasing hormone, and aromatase inhibitor on simultaneous outputs of progesterone, 17 beta-estradiol, and human chorionic gonadotropin by term placental explants.
Topics: Androstenedione; Bucladesine; Cholesterol; Cholesterol, LDL; Chorionic Gonadotropin; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Synergism; Estradiol; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Humans; Lipoproteins, LDL; Placenta; Pregnancy; Progesterone | 1982 |
The synthesis of 19-norandrostenedione from dehydroepiandrosterone in equine placenta is inhibited by aromatase inhibitors 4-hydroxyandrostenedione and fadrozole.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Dehydroepiandrosterone; Enzyme Inhibitors; Fadrozole; Female; Horses; Placenta; Pregnancy | 1995 |
Dehydroepiandrosterone stimulates the estrogen response element.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Cell Line; Dehydroepiandrosterone; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fulvestrant; Genes, Reporter; Genetic Vectors; Humans; Luciferases; Mice; Receptors, Estrogen; Transfection | 1997 |
Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol.
Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Chromatography, Thin Layer; Dehydroepiandrosterone; Dexamethasone; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Immunoassay; Mitogens; Tamoxifen; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 2001 |
Computer-aided structure analysis of an epimerized dehydroepiandrosterone derivative and its biological effect in a model of reactive gliosis.
Topics: Androstadienes; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Crystallography, X-Ray; Dehydroepiandrosterone; Glial Fibrillary Acidic Protein; Gliosis; Male; Molecular Sequence Data; Molecular Structure; Rats; Rats, Wistar | 2010 |